Perrigo Announces FDA Approval For Generic Equivalent to Zantac

Allegan-based Perrigo Co. (Nasdaq: PRGO) announced that it has received final approval from the United States Food and Drug Administration for its abbreviated new drug application for over-the-counter Ranitidine 150 (regular and cool mint), a generic version of Zantac 150.

WWJ Newsradio 950–05/16/2011